购物车
- 全部删除
- 您的购物车当前为空
MG-115 (Z-LL-Nva-CHO) 是一种有效且可逆的蛋白酶体抑制剂,对20S 和26S 蛋白酶体的 Ki 值分别为 21 nM 和 35 nM。MG-115 特异性抑制蛋白酶体的胰凝乳蛋白酶样活性,诱导 p53 依赖性细胞凋亡。
为众多的药物研发团队赋能,
让新药发现更简单!
MG-115 (Z-LL-Nva-CHO) 是一种有效且可逆的蛋白酶体抑制剂,对20S 和26S 蛋白酶体的 Ki 值分别为 21 nM 和 35 nM。MG-115 特异性抑制蛋白酶体的胰凝乳蛋白酶样活性,诱导 p53 依赖性细胞凋亡。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 413 | 现货 | |
5 mg | ¥ 592 | 现货 | |
10 mg | ¥ 996 | 现货 | |
25 mg | ¥ 1,960 | 现货 | |
50 mg | ¥ 3,430 | 现货 | |
100 mg | ¥ 4,650 | 现货 | |
200 mg | ¥ 6,270 | 现货 |
产品描述 | MG-115 (Z-LL-Nva-CHO) is a potent and reversible inhibitor of proteasome , with K i s of 21 nM and 35 nM for 20S and 26S proteasome, respectively. MG-115 specifically inhibit the chymotrypsin-like activity of the proteasome, induces p53-dependent apoptosis [1] [2] [3]. |
体外活性 | MG-115 (0.1-10 μM; 24 h) decreases the viability of HepG2 cells in a dose-dependent manner [3]. MG-115 (0.1-10 μM; 24 h) amplifies the reporter gene expression mediated by CWK 18 DNA condensates [3]. Cell Viability Assay [3] Cell Line: HepG2 cells Concentration: 0.1, 1, 2, 5, 10 μM Incubation Time: 24 hours Result: Dose-dependently decreased cell viability. Inhibited the proteasomal activity, with an IC 50 of 2 μM. |
别名 | Z-LL-Nva-CHO |
分子量 | 461.59 |
分子式 | C25H39N3O5 |
CAS No. | 133407-86-0 |
Smiles | CCCC(NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1)C=O |
密度 | 1.082 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 45 mg/mL (97.5 mM) | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容